CAS: 1338225-97-0; 3-Chloro-5-((1-((4-Methyl-5-Oxo-4,5-Dihydro-1H-1,2,4-Triazol-3-yl)Methyl)-2-Oxo-4-(Trifluoromethyl)-1,2-Dihydropyridin-3-yl)Oxy)Benzonitrile

该化合物是一种主要用于治疗艾滋病毒-1感染的抗逆转录酶药物,属于非核循环反转转录酶抑制剂(NNRTIs)和功能,抑制对病毒复制至关重要的反转录酶酶,多瑙河的特点是,它高度选择艾滋病毒-1酶,有助于最大限度地减少目标外效应和潜在毒性;复合物呈现一种有利的药用动因特征,允许每天一次服用,而无需食物限制;其化学结构包括双环核心,有助于其稳定和有效对付各种艾滋病毒菌株,包括抗其他NRTIs的抗药性;与旧NRTIs相比,多瑙河道的...

结构式图片

上下游产品

3-Chloro-5-((2-Oxo-1-((5-Oxo-4,5-Dihydro-1H-1,2,4-Triazol-3-yl)Methyl)-4-(Trifluoromethyl)-1,2-Dihydropyridin-3-yl)Oxy)Benzonitrile 1338226-05-3
3-Chloro-5-((1-((1-(2-Methoxypropan-2-yl)-4-Methyl-5-Oxo-4,5-Dihydro-1H-1,2,4-Triazol-3-yl)Methyl)-2-Oxo-4-(Trifluoromethyl)-1,2-Dihydropyridin-3-yl)Oxy)Benzonitrile 1613307-25-7
3-氯-5-[[2-氧代-4-(三氟甲基)-1,2-二氢吡啶-3-基]氧基]苯甲腈 3-Chloro-5-((2-Oxo-4-(Trifluoromethyl)-1,2-Dihydropyridin-3-yl)Oxy)Benzonitrile 1155846-86-8
3-(3-Bromo-5-Chlorooxy)-4-(Trifluoromethyl)Pyridin-2(1H)-One 1155846-88-0

合成工艺路线路线简述

    📜3-Chloro-5-((1-((1-(2-Methoxypropan-2-yl)-4-Methyl-5-Oxo-4,5-Dihydro-1H-1,2,4-Triazol-3-yl)Methyl)-2-Oxo-4-(Trifluoromethyl)-1,2-Dihydropyridin-3-yl)Oxy)Benzonitrile 以46的收率获得多拉韦林
    参考文献: Process For Making Reverse Transcriptase Inhibitors[fr] Procédé De Préparation D'Inhibiteurs De Transcriptase Inverse
    标题: Process For Making Reverse Transcriptase Inhibitors[fr] Procédé De Préparation D'Inhibiteurs De Transcriptase Inverse
    摘要:本发明涉及一种合成3-(取代苯氧基)-1-[(5-氧代-4,5-二氢-1H-1,2,4-三唑-3-基)甲基]-吡啶-2(1H)-酮衍生物的新工艺.本发明的合成方法所得到的化合物是hiv反转录酶抑制剂,可用于抑制反转录酶,Hiv复制以及治疗人体免疫缺陷病毒感染.

    海关参考信息

    专利信息


    专利号:US-2025179033-A1
    优先权日:2021-12-30
    标 题 :New antiviral triazole derivatives, their synthesis and their use for treatment of mammalian viral infections
    发明人:MAKAROV VADIM; RIABOVA OLGA; LANE THOMAS R; EKINS SEAN
    权利人:COLLABORATIONS PHARMACEUTICALS INC; FEDERAL RES CENTER FUNDAMENTALS OF BIOTECHNOLOGY RUSSIAN ACADEMY OF SCIENCE
    摘要:A family of triazole derivatives is described. Also described is the use of these triazole derivatives in treating or preventing viral infections, such as human immunodeficiency virus (HIV) infections, and the diseases caused by these infections, such as acquired immunodeficiency syndrome (AIDS). The triazole derivatives, for example, comprise a central triazole group with two substituents comprising an aryl or heteroaryl group. Exemplary derivatives showed excellent HIV inhibitory activity against both wild-type and selected mutant strains of HIV.

    专利号:WO-2025124470-A1
    优先权日:2023-12-15
    标 题:Doravirine intermediate, and use thereof and synthesis method therefor
    发明人:GAO ZHANGBIN; WEN SHAOPENG; YANG JINHONG; JU JINGJING; MAO WENXIU
    权利人:SHANDONG CHENGCHUANG BLUE SEA PHARMACEUTICAL TECH CO LTD
    摘要:The present invention relates to a doravirine intermediate, and the use thereof and a synthesis method therefor, which belong to the technical field of pharmaceutical chemistry. The method for synthesizing the doravirine intermediate comprises the following steps: (1) mixing ethyl 2-fluoroacetate with 4-ethoxy-1,1,1-trifluoro-3-buten-2-one with solvent I, and then dropwise adding sodium bis(trimethylsilyl)amide to form compound 1; (2) adding an ammonia source into the reaction liquid of compound 1 to obtain compound 2; (3) dissolving compound 2 in solvent II, adding a catalyst, and heating and ring-closing the mixture to obtain compound 3; and (4) dissolving compound 3 in toluene, adding thionyl chloride, and dropwise adding pyridine to obtain 2-hydroxy-3-fluoro-4-trifluoromethylpyridine. The synthesis method of the present invention has a low raw material cost and a short process period, is environmentally friendly, and is suitable for process scaled-up production.

    专利号:WO-2025124469-A1
    优先权日:2023-12-15
    标 题 :Method for synthesizing doravirine intermediate
    发明人:GAO ZHANGBIN; XU FANGHUI; ZHAO XINYU; JU JINGJING; MAO WENXIU
    权利人:SHANDONG CHENGCHUANG BLUE SEA PHARMACEUTICAL TECH CO LTD
    摘要:The present invention relates to the technical field of pharmaceutical chemistry, and to a method for synthesizing a doravirine intermediate. The synthesis method of the present invention comprises: (1) mixing ethyl 2-fluoroacetate with 4-ethoxy-1,1,1-trifluoro-3-buten-2-one in a first solvent and adding sodium bis(trimethylsilyl)amide for a reaction to generate compound 1; (2) adding triethylamine and trifluoroacetic anhydride to a reaction solution of compound 1 for a reaction to generate compound 2; (3) adding an ammonia source to a reaction solution of compound 2 to obtain compound 3 and compound 4; and (4) adding a second solvent and heating the resulting mixture for cyclization to obtain 2-hydroxy-3-fluoro-4-trifluoromethylpyridine. The present invention has low raw material cost and is a synthesis method, which has a short process cycle, is environmentally friendly, and is suitable for scale-up process production.

    专利号:WO-2023128786-A1
    优先权日:2021-12-30
    标 题:New antiviral triazole derivatives, their synthesis and their use for treatment of mammalian viral infections

    专利号:EP-4457218-A1
    优先权日:2021-12-30
    标题:New antiviral triazole derivatives, their synthesis and their use for treatment of mammalian viral infections

    专利号:CN-117304094-A
    优先权日:2023-09-21
    标 题 :Synthesis method of 3-trifluoromethyl pyridine or 3-difluoro methyl pyridine compound

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Doravirine. 2025 Nov 15. 26(1):9-15. doi: 10.1080/14656566.2024.2440000. Epub 2024 Dec 10.
    13:676831. doi: 10.3389/fphar.2022.676831.
    4: Stockdale AJ, Khoo S. Doravirine: its role in HIV treatment. Curr Opin HIV AIDS. 2022 Jan 1;17(1):4-14. doi: 10.1097/COH.0000000000000709. 28(9):10576-10588. doi: 10.1007/s11356-020-11267-0. Epub 2020 Oct 24. 85(5):635-642. doi: 10.1097/QAI.0000000000002496.

    合成参考文献


    摘要:Caron, S.; Lee, J.; Liu, Y.; Nguyen, T. N.; Piper, J. L.; Vicini, A. C., Science of Synthesis: Modern Strategies in Organofluorine Chemistry, (2025) 2.
    参考文献:10.1177/2168479017750129
    摘要:Baldrick P. Juvenile Animal Testing: Assessing Need and Use in the Drug Product Label. Ther Innov Regul Sci. 2018 Sep;52(5):641–8. doi: 10.1177/2168479017750129.
    参考文献:10.1186/s12977-019-0479-9
    摘要:Trinité B, Zhang H, Levy DN. NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal. Retrovirology. 2019 Jun 26;16(1):17.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知